Analyzing Incomplete Discrete Longitudinal Clinical Trial Data by Jansen, Ivy et al.
ar
X
iv
:m
at
h/
06
06
49
7v
1 
 [m
ath
.ST
]  
20
 Ju
n 2
00
6
Statistical Science
2006, Vol. 21, No. 1, 52–69
DOI: 10.1214/088342305000000322
c© Institute of Mathematical Statistics, 2006
Analyzing Incomplete Discrete
Longitudinal Clinical Trial Data
Ivy Jansen, Caroline Beunckens, Geert Molenberghs, Geert Verbeke and Craig Mallinckrodt
Abstract. Commonly used methods to analyze incomplete longitudi-
nal clinical trial data include complete case analysis (CC) and last
observation carried forward (LOCF). However, such methods rest on
strong assumptions, including missing completely at random (MCAR)
for CC and unchanging profile after dropout for LOCF. Such assump-
tions are too strong to generally hold. Over the last decades, a number
of full longitudinal data analysis methods have become available, such
as the linear mixed model for Gaussian outcomes, that are valid un-
der the much weaker missing at random (MAR) assumption. Such a
method is useful, even if the scientific question is in terms of a sin-
gle time point, for example, the last planned measurement occasion,
and it is generally consistent with the intention-to-treat principle. The
validity of such a method rests on the use of maximum likelihood, un-
der which the missing data mechanism is ignorable as soon as it is
MAR. In this paper, we will focus on non-Gaussian outcomes, such as
binary, categorical or count data. This setting is less straightforward
since there is no unambiguous counterpart to the linear mixed model.
We first provide an overview of the various modeling frameworks for
non-Gaussian longitudinal data, and subsequently focus on generalized
linear mixed-effects models, on the one hand, of which the parameters
can be estimated using full likelihood, and on generalized estimating
equations, on the other hand, which is a nonlikelihood method and
hence requires a modification to be valid under MAR. We briefly com-
ment on the position of models that assume missingness not at random
and argue they are most useful to perform sensitivity analysis. Our
developments are underscored using data from two studies. While the
case studies feature binary outcomes, the methodology applies equally
well to other discrete-data settings, hence the qualifier “discrete” in the
title.
Key words and phrases: Complete case analysis, ignorability, gener-
alized estimating equations, generalized linear mixed models, last ob-
servation carried forward, missing at random, missing completely at
random, missing not at random, sensitivity analysis.
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1. INTRODUCTION
Data from longitudinal studies, in general, and
from clinical trials, in particular, are prone to incom-
pleteness. Dropout is a special case of incomplete-
ness. Since incompleteness usually occurs for reasons
outside the control of the investigators and may be
related to the outcome measurement of interest, it is
generally necessary to address the process that gov-
erns incompleteness. Only in special but important
cases is it possible to ignore the missingness process.
When referring to the missing-value, or nonre-
sponse, process, we will use the terminology of Little
and Rubin (2002, Chapter 6). A nonresponse process
is said to be missing completely at random (MCAR)
if the missingness is independent of both unobserved
and observed data, and said to be missing at ran-
dom (MAR) if, conditional on the observed data,
the missingness is independent of the unobserved
measurements. A process that is neither MCAR nor
MAR is termed nonrandom (MNAR). In the con-
text of likelihood inference, and when the parame-
ters that describe the measurement process are func-
tionally independent of the parameters that describe
the missingness process, MCAR and MAR are ig-
norable, while a nonrandom process is nonignorable.
Early work regarding missingness focused on the
consequences of the induced lack of balance of devia-
tions from the study design (Afifi and Elashoff, 1966;
Hartley and Hocking, 1971). Later, algorithmic de-
velopments took place, such as the expectation–maxi-
mization algorithm (EM; Dempster, Laird and Ru-
bin, 1977) and multiple imputation (Rubin, 1987).
These advances have brought likelihood-based ig-
norable analysis within reach for a large class of
designs and models. However, they usually require
extra programming in addition to available standard
statistical software.
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In the meantime, however, clinical trial practice
has put a strong emphasis on such methods as com-
plete case analysis (CC), which restricts the anal-
ysis to those subjects for which all information has
been measured according to protocol, and last obser-
vation carried forward (LOCF), for which the last
observed measurement is substituted for values at
later points in time that are not observed, or other
simple forms of imputation. Claimed advantages in-
clude computational simplicity, no need for a full
longitudinal model (e.g., when the scientific ques-
tion is in terms of the last planned measurement oc-
casion only) and, for LOCF, compatibility with the
intention-to-treat (ITT) principle. Within the Gaus-
sian setting, Molenberghs et al. (2004) have argued
that this focus is understandable, but, given current
computational resources, unfortunate. They suggest
the use of a likelihood-based ignorable analysis, for
example, based on the linear mixed-effects model.
Such a method requires MAR rather than the much
stronger assumptions that underlie CC and LOCF,
and uses all data, obviating the need for both delet-
ing and filling in data, and is thus consistent with
the intention-to-treat principle. Nevertheless, care
has to be taken when subjects are discontinued for
reasons of noncompliance, since then the modes of
analysis indicated here would assume that treatment
is unchanged after dropout. This implies the need
for sensitivity analysis and an important discussion
of this point has been given by Fitzmaurice (2003).
Molenberghs et al. (2004) also show that the incom-
plete sequences contribute to estimands of interest,
even early dropouts when scientific interest is in the
last planned measurement only. Finally, they show
that such an analysis is possible, without the need
for any additional data manipulation, using, for ex-
ample, the SAS procedure MIXED or the SPlus or
R function lme. Of course, a longitudinal model has
to be specified for the entire vector of responses. In
a clinical trial setting, with relatively short and bal-
anced response sequences, full multivariate models,
encompassing full treatment-by-group interactions,
perhaps corrected for baseline covariates, and an un-
structured variance–covariance matrix, are usually
within reach. A model of this type is relatively mild
in the restrictions made.
The non-Gaussian setting is different in the sense
that there is no generally accepted counterpart to
the linear mixed-effects model. We therefore first
sketch a general taxonomy for longitudinal models in
this context, including marginal, random-effects (or
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subject-specific) and conditional models. We then
argue that marginal and random-effects models both
have their merits in the analysis of longitudinal clin-
ical trial data and we focus on two important repre-
sentatives, that is, the generalized estimating equa-
tions (GEE) approach within the marginal family
and the generalized linear mixed-effects model
(GLMM) within the random-effects family. We high-
light important similarities and differences between
these model families. While GLMM parameters can
be fitted using maximum likelihood, the same is not
true for the GEE method, which is of a frequen-
tist nature. Therefore, Robins, Rotnitzky and Zhao
(1995) have devised so-called weighted generalized
estimating equations (WGEE), which are valid un-
der MAR but require the specification of a dropout
model in terms of observed outcomes and/or covari-
ates, in view of specifying the weights. Thus, we be-
lieve that, generally, methods such as complete case
analysis or LOCF ought to be abandoned in favor
of the likelihood-based and weighted GEE models
discussed here.
By definition, MNAR missingness cannot be fully
ruled out based on the observed data. Nevertheless,
ignorable analyses may provide reasonably stable re-
sults, even when the assumption of MAR is violated,
in the sense that such analyses constrain the behav-
ior of the unseen data to be similar to that of the
observed data. A discussion of this phenomenon in
the survey context has been given in Rubin, Stern
and Vehovar (1995). These authors first argue that,
in well-conducted experiments (some surveys and
many confirmatory clinical trials), the assumption
of MAR is often to be regarded as a realistic one.
Second, and very important for confirmatory trials,
an MAR analysis can be specified a priori without
additional work relative to a situation with complete
data. Third, while MNAR models are more general
and explicitly incorporate the dropout mechanism,
the inferences they produce are typically highly de-
pendent on the untestable and often implicit built-in
assumptions regarding the distribution of the unob-
served measurements given the observed ones. The
quality of the fit to the observed data need not re-
flect at all the appropriateness of the implied struc-
ture that governs the unobserved data. Based on
these considerations, we recommend, for primary
analysis purposes, the use of ignorable likelihood-
based methods or appropriately modified frequentist
methods. To explore the impact of deviations from
the MAR assumption on the conclusions, one should
ideally conduct a sensitivity analysis (Verbeke and
Molenberghs, 2000, Chapters 18–20).
Two case studies motivate our work. The first
one arises from a randomized, double-blind psychi-
atric clinical trial conducted in the United States.
The primary objective of this trial was to compare
the efficacy of an experimental anti-depressant with
placebo in order to support a new drug application.
The study enrolled 167 patients. The Hamilton de-
pression rating scale (HAMD17) is used to measure
the depression status of the patients. The binary in-
dicator of interest is 1 if the HAMD17 score is greater
than 7, and 0 otherwise. For each patient, a baseline
assessment is available, as well as eight post-baseline
visits going from visit 4 to visit 11.
The second case study arises from a randomized
multicentric clinical trial that compared an experi-
mental treatment (interferon-α) to a corresponding
placebo in the treatment of patients with age-related
macular degeneration. Interest focuses on the com-
parison between placebo and the highest dose (6 mil-
lion units daily) of interferon-α (Z), but the full
results of this trial have been reported elsewhere
(Pharmacological Therapy for Macular Degenera-
tion Study Group, 1997). Patients with macular de-
generation progressively lose vision. In the trial, the
patients’ visual acuity was assessed at different time
points (4 weeks, 12 weeks, 24 weeks and 52 weeks)
through their ability to read lines of letters on stan-
dardized vision charts. These charts display lines of
five letters of decreasing size, which the patient must
read from top (largest letters) to bottom (smallest
letters). Each line with at least four letters correctly
read is called one line of vision. The patient’s visual
acuity is the total number of letters correctly read.
The primary endpoint of the trial was the loss of
at least three lines of vision at 1 year, compared to
their baseline performance (i.e., a binary endpoint).
The total number of longitudinal profiles is 240, but
only for 188 of these have the four follow-up mea-
surements been made. An overview is given in Ta-
ble 1. Thus, 78.33% of the profiles are complete,
while 18.33% exhibit monotone missingness. Out of
the latter group, 2.5% or six subjects have no follow-
up measurements. The remaining 3.33%, represent-
ing eight subjects, have intermittent missing values.
Although the group of dropouts is of considerable
magnitude, the ones with intermittent missingness
is much smaller. Nevertheless, it is cautious to in-
clude all data in the analyses. Data on this second
case study are available on the author’s website.
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Table 1
Age related macular degeneration trial: Overview of
missingness patterns and the frequencies with which they
occur (O indicates observed and M indicates missing)
Measurement occasion (weeks)
4 12 24 52 Number %
Completers
O O O O 188 78.33
Dropouts
O O O M 24 10.00
O O M M 8 3.33
O M M M 6 2.50
M M M M 6 2.50
Nonmonotone missingness
O O M O 4 1.67
O M M O 1 0.42
M O O O 2 0.83
M O M M 1 0.42
The general data setting is introduced in Section 2,
as well as a formal framework for incomplete longi-
tudinal data, together with a discussion of the prob-
lems associated with simple methods. Section 3 fo-
cuses on two important families of models for dis-
crete repeated measures. The first case study is an-
alyzed in Section 4, while the second one is the sub-
ject of Section 5. The paper ends with a discussion
in Section 6.
2. DATA SETTING AND MODELING
FRAMEWORK
Assume that for subject i = 1, . . . ,N a sequence
of responses Yij is designed to be measured at oc-
casions j = 1, . . . , n. The outcomes are grouped into
a vector Yi = (Yi1, . . . , Yin)
′. In addition, for each
occasion j, define Rij as being equal to 1 if Yij is
observed and 0 otherwise. The missing data indica-
tors Rij are grouped into a vector Ri, which is of
the same length as Yi. Define now a dropout indica-
tor Di for the occasion at which dropout occurs and
make the convention that Di = n+1 for a complete
sequence. Further, split the vector Yi into observed
(Yoi ) and missing (Y
m
i ) components, respectively.
Modeling usually is initiated by considering the
full data density f(yi, di|θ,ψ), where the parame-
ter vectors θ and ψ describe the measurement and
missingness processes, respectively. Covariates are
assumed to be measured, but for notational simplic-
ity are suppressed from notation.
Most strategies used to analyze such data are,
implicitly or explicitly, based on the following two
choices.
Model for measurements. A choice has to be made
regarding the modeling approach to the measure-
ments. There are three common views. In the first
view, one opts to analyze the entire longitudinal pro-
file, irrespective of whether interest focuses on the
entire profile, on the one hand (e.g., difference in
slope between groups), or whether a specific time is
of interest, on the other hand (e.g., the last planned
occasion). In the latter case, the motivation to model
the entire profile is because, for example, earlier re-
sponses do provide statistical information on later
ones. This is especially true when dropout is present.
In the second view, one defines the scientific ques-
tion and restricts the corresponding analysis to the
last planned occasion. Of course, as soon as dropout
occurs, such a measurement may not be available,
whence often last observation carried forward is used.
Such an analysis is based on strong assumptions
that often do not hold. This point has been made
extensively in Molenberghs et al. (2004). These au-
thors advocate the use of proper, likelihood-based,
longitudinal methods, which are generally valid un-
der MAR. In the third view, one chooses to define
the question and the corresponding analysis in terms
of the last observed measurement. While sometimes
used as an alternative motivation for so-called last
observation carried forward analyses (Siddiqui and
Ali, 1998; Mallinckrodt, Clark, Carroll and Molenberghs,
2003a; Mallinckrodt et al., 2003b), a common crit-
icism is that the last observed measurement amal-
gamates measurements at real stopping times (for
dropouts) and at a purely design-based time (for
completers). Thus, we hope to show that the first
view is in many situations the most sensible route
of analysis.
Method for handling missingness. A choice has to
be made regarding the modeling approach to the
missingness model. Luckily, under certain assump-
tions this process can be ignored (likelihood-based
or Bayesian ignorable analysis, for which MAR is a
sufficient condition). Some simple methods such as
CC analysis and LOCF do not explicitly address the
missingness mechanism either, but are nevertheless
not ignorable. We will return to this issue in the
next section.
Let us first describe the measurement and miss-
ingness models in turn, and then introduce and com-
ment on ignorability. The measurement model will
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depend on whether or not a full longitudinal analysis
is done. In case the second or third view is adopted,
one typically opts for classical two-group or multi-
group comparisons (t test, Wilcoxon, etc.). In case a
longitudinal analysis is deemed necessary, the choice
made depends on the nature of the outcome.
For continuous outcomes, a common choice is the
general linear mixed-effects model or a special case
of it, such as a (structured) multivariate normal
model (Verbeke and Molenberghs, 2000). However,
for categorical (nominal, ordinal and binary) and
discrete outcomes (counts), as in our case study,
the modeling choices are less straightforward. Ex-
tensions of the generalized linear models to the lon-
gitudinal case were discussed by Diggle, Heagerty,
Liang and Zeger (2002), where a lot of emphasis is on
generalized estimating equations (Liang and Zeger,
1986). Generalized linear mixed models have been
proposed and/or studied by, for example, Stiratelli,
Laird and Ware (1984), Wolfinger and O’Connell
(1993) and Breslow and Clayton (1993). Fahrmeir
and Tutz (2001) devoted an entire book to general-
ized linear models for multivariate settings. We re-
turn to modeling non-Gaussian repeated measures
in Section 3. It is important to note that, since quite
distinct modeling families are in use, the researcher
ought to be guided by the main scientific question at
hand when choosing between the modeling families.
Assume that incompleteness is due to dropout
only and that the first measurement Yi1 is obtained
for everyone. The model for the dropout process is
based on, for example, a logistic regression for the
probability of dropout at occasion j, given the sub-
ject is still in the study. We denote this probability
by g(hij , yij), in which hij is a vector that contains
all responses observed up to but not including occa-
sion j, as well as relevant covariates. We then assume
that g(hij , yij) satisfies
logit[g(hij , yij)]
= logit[pr(Di = j|Di ≥ j,yi)](1)
= hijψ+ ωyij, i= 1, . . . ,N.
When ω equals zero, and assuming the posited model
is correct, the dropout model is MAR. If ω 6= 0, the
posited dropout process is MNAR. Model (1) pro-
vides the building blocks for the dropout process
f(di|yi,ψ).
Rubin (1976) and Little and Rubin (2002) have
shown that, under MAR and mild regularity condi-
tions (parameters θ and ψ are functionally indepen-
dent), likelihood-based and Bayesian inference are
valid when the missing data mechanism is ignored
(see also Verbeke and Molenberghs, 2000). Prac-
tically speaking, the likelihood of interest is then
based on the factor f(yoi |θ). This is called ignorabil-
ity. A model of the form (1), of course with ω = 0,
may but does not have to be considered in such a
case. The practical implication is that a software
module with likelihood estimation facilities and with
the ability to deal with incompletely observed sub-
jects manipulates the correct likelihood, providing
valid parameter estimates, standard errors if based
on the observed information matrix and likelihood
ratio values (Kenward and Molenberghs, 1998). Ex-
amples of such software tools include the MIXED,
NLMIXED and GENMOD procedures in SAS.
A few cautionary remarks are in order. First, when
at least part of the scientific interest is directed to-
ward the nonresponse process, obviously both pro-
cesses need to be considered. Still, under MAR, both
processes can be modeled and parameters can be es-
timated separately. Second, it may be hard to fully
rule out the operation of an MNAR mechanism.
Third, one is now restricted to the first view on mod-
eling the outcomes, that is, a full longitudinal anal-
ysis is necessary, even when interest is restricted to,
for example, a comparison between the two treat-
ment groups at the last occasion. In the latter case,
the fitted model can be used as the basis for in-
ference at the last occasion. A common criticism,
especially in a regulated controlled clinical trial set-
ting, is that a model needs to be considered. How-
ever, it should be noted that in many clinical trial
settings the repeated measures are balanced in the
sense that a common (and often limited) set of mea-
surement times is considered for all subjects, allow-
ing the a priori (protocol) specification of a sat-
urated model (e.g., full group-by-time interaction
model for the means and unstructured variance–
covariance matrix).
Such an ignorable linear mixed model specifica-
tion is termed mixed-effects model repeated mea-
sures (MMRM) by Mallinckrodt, Clark and David
(2001a, b). Thus, MMRM is a particular form of a
linear mixed model, relevant for acute phase con-
firmatory clinical trials, fitting within the ignorable
likelihood paradigm. It has to be noted that this ap-
proach, for the special case where no dropout occurs,
is fully equivalent to a one-way multivariate analysis
of variance model for the repeated outcomes, with
a class variable treatment effect. This observation
provides a strong basis for such an approach, which
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is a very promising alternative for the simple ad hoc
methods such as complete-case analysis or LOCF.
While the above reasoning is tied to the continuous-
outcome setting, similar modeling strategies exist
for the non-Gaussian case, as discussed in Section 3.
These arguments, supplemented with the avail-
ability of software tools within which such multi-
variate models can be fitted to incomplete data, cast
doubts regarding the usefulness of such simple meth-
ods as CC and LOCF. This issue has been discussed
in detail, in the context of Gaussian outcomes, by
Molenberghs et al. (2004). Apart from biases as soon
as the missing data mechanism is not MCAR, CC
can suffer from severe efficiency losses. Especially
since tools have become available to include incom-
plete sequences along with complete ones into the
analysis, one should do everything possible to avoid
wasting patient data.
Last observation carried forward, as other impu-
tation strategies (Dempster and Rubin, 1983; Little
and Rubin, 2002), can lead to artificially inflated
precision. Furthermore as Molenberghs et al. (2004)
have shown, the method can produce severely bi-
ased treatment comparisons and, perhaps contrary
to some common belief, such biases can be conserva-
tive but also liberal. The method rests on the strong
assumption that a patient’s outcome profile remains
flat, at the level of the last observed measurement,
throughout the remainder of follow-up.
3. DISCRETE REPEATED MEASURES
Whereas the linear mixed model and its special
cases is seen as a unifying parametric framework for
Gaussian repeated measures (Verbeke and
Molenberghs, 2000), there are many more options
available in the non-Gaussian setting. In a marginal
model, marginal distributions are used to describe
the outcome vector Y, given a set X of predic-
tor variables. The correlation among the compo-
nents of Y can then be captured either by adopting
a fully parametric approach or by means of work-
ing assumptions, such as in the semiparametric ap-
proach of Liang and Zeger (1986). Alternatively, in
a random-effects model, the predictor variables X
are supplemented with a vector θ of random effects,
conditional upon which the components of Y are
usually assumed to be independent. This does not
preclude that more elaborate models are possible if
residual dependence is detected (Longford, 1993).
Finally, a conditional model describes the distribu-
tion of the components of Y, conditional on X but
also conditional on (a subset of ) the other compo-
nents of Y. Well-known members of this class of
models are log-linear models (Gilula and Haberman,
1994).
Let us give a simple example of each for the case
of Gaussian outcomes. A marginal model starts by
specifying
E(Yij |xij) = x′ijβ,(2)
whereas in a random-effects model we focus on the
expectation, conditional upon the random-effects vec-
tor,
E(Yij |bi,xij) = x′ijβ+ z′ijbi.(3)
The conditional model uses expectations of the form
E(Yij |Yi,j−1, . . . , Yi1,xij) = x′ijβ+αYi,j−1.(4)
In the linear mixed model case, random-effects mod-
els imply a simple marginal model. This is due to the
elegant properties of the multivariate normal dis-
tribution. In particular, the expectation (2) follows
from (3) either by (a) marginalizing over the random
effects or by (b) conditioning on the random-effects
vector bi = 0. Hence, the fixed-effects parameters β
have both a marginal as well as a hierarchical model
interpretation.
Since marginal and random-effects models are the
most useful ones in our context and given this con-
nection between them, it is clear why the linear
mixed model provides a unified framework in the
Gaussian setting. Such a close connection between
the model families does not exist when outcomes
are of a nonnormal type, such as binary, categor-
ical or discrete. We will consider the marginal and
random-effects model families in turn and then point
to some particular issues that arise within them or
when comparisons are made between them. The con-
ditional models are less useful in the context of longi-
tudinal data and will not be discussed here (Molen-
berghs and Verbeke, 2005).
3.1 Marginal Models
Thorough discussions on marginal modeling can
be found in Diggle, Heagerty, Liang and Zeger (2002)
and Fahrmeir and Tutz (2001). The specific context
of clustered binary data has received treatment in
Aerts, Geys, Molenberghs and Ryan (2002). Apart
from full likelihood approaches, nonlikelihood ap-
proaches such as generalized estimating equations
(Liang and Zeger, 1986) or pseudolikelihood (le Cessie
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and van Houwelingen, 1994; Geys, Molenberghs and
Lipsitz, 1998) have been considered.
Bahadur (1961) proposed a marginal model, ac-
counting for the association via marginal correla-
tions. Ekholm (1991) proposed a so-called success
probabilities approach. Bowman and George (1995)
proposed a model for the particular case of exchange-
able binary data. Ashford and Sowden (1970) con-
sidered the multivariate probit model for repeated
ordinal data, thereby extending univariate probit re-
gression. Molenberghs and Lesaffre (1994) and Lang
and Agresti (1994) proposed models that parame-
terize the association in terms of marginal odds ra-
tios. Dale (1986) defined the bivariate global odds
ratio model, based on a bivariate Plackett distri-
bution (Plackett, 1965). Molenberghs and Lesaffre
(1994, 1999), Lang and Agresti (1994) and Glonek
and McCullagh (1995) extended this model to mul-
tivariate ordinal outcomes. They generalized the bi-
variate Plackett distribution in order to establish the
multivariate cell probabilities.
While full likelihood methods are appealing be-
cause of their flexible ignorability properties (Sec-
tion 2), their use for non-Gaussian outcomes can
be problematic due to prohibitive computational re-
quirements. Therefore, GEE is a viable alternative
within this family. Since GEE is motivated by fre-
quentist considerations, the missing data mechanism
needs to be MCAR for it to be ignorable. This moti-
vates the proposal of so-called weighted generalized
estimating equations. We will discuss these in turn.
3.1.1 Generalized estimating equations. General-
ized estimating equations, useful to circumvent the
computational complexity of full likelihood, can be
considered whenever interest is restricted to the mean
parameters (treatment difference, time evolutions,
effect of baseline covariates, etc.). It is rooted in
the quasi-likelihood ideas expressed by McCullagh
and Nelder (1989). Modeling is restricted to the cor-
rect specification of the marginal mean function, to-
gether with so-called working assumptions about the
correlation structure of the vector of repeated mea-
sures.
Let us now introduce the classical form of GEE.
Note that the score equations to be solved when
computing maximum likelihood estimates under a
marginal normal model yi ∼ N(Xiβ, Vi) are given
by
N∑
i=1
X ′i(A
1/2
i CiA
1/2
i )
−1(yi −Xiβ) = 0,(5)
in which the marginal covariance matrix Vi has been
decomposed in the form A
1/2
i CiA
1/2
i , where Ai is
the matrix with the marginal variances on the main
diagonal and zeros elsewhere, and Ci is equal to the
marginal correlation matrix. Switching to the non-
Gaussian case, the score equations become
S(β) =
N∑
i=1
∂µi
∂β′
(A
1/2
i CiA
1/2
i )
−1(yi −µi) = 0,(6)
which are less linear than (5) due to the presence of a
link function (e.g., the logit link for binary data) and
the mean–variance relationship. Typically the cor-
relation matrix Ci contains a vector α of unknown
parameters that is replaced for practical purposes
by a consistent estimate.
Assuming that the marginal mean µi has been
correctly specified as h(µi) =Xiβ, it can be shown
that, under mild regularity conditions, the estimator
β̂ obtained by solving (6) is asymptotically normally
distributed with mean β and with covariance matrix
I−10 I1I
−1
0 ,(7)
where
I0 =
(
N∑
i=1
∂µ′i
∂β
V −1i
∂µi
∂β′
)
,
I1 =
(
N∑
i=1
∂µ′i
∂β
V −1i Var(yi)V
−1
i
∂µi
∂β′
)
.
In practice, Var(yi) in (7) is replaced by (yi −µi) ·
(yi − µi)′, which is unbiased on the sole condition
of correct mean specification. One also needs es-
timates of the nuisance parameters α. Liang and
Zeger (1986) proposed moment-based estimates for
the working correlation. To this end, define devia-
tions
eij =
yij − µij√
v(µij)
.
Some of the more popular choices for the work-
ing correlations are independence [Corr(Yij , Yik) =
0, j 6= k], exchangeability [Corr(Yij , Yik) = α, j 6= k],
AR(1) [Corr(Yij , Yi,j+t) = α
t, t= 0,1, . . . , ni− j] and
unstructured [Corr(Yij , Yik) = αjk, j 6= k]. Typically,
moment-based estimation methods are used to esti-
mate these parameters as part of an integrated it-
erative estimation procedure. An overdispersion pa-
rameter could be included as well, but we have sup-
pressed it for ease of exposition. The standard it-
erative procedure to fit GEE, based on Liang and
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Zeger (1986), is then as follows: (1) compute initial
estimates for β using a univariate generalized linear
model (i.e., assuming independence); (2) compute
the quantities bi needed in the estimating equa-
tion; (3) compute Pearson residuals eij ; (4) compute
estimates for α; (5) compute Ci(α); (6) compute
Vi(β,α) =A
1/2
i (β)Ci(α)A
1/2
i (β); (7) update the es-
timate for β:
β(t+1) = β(t) −
[
N∑
i=1
∂µ′i
∂β
V −1i
∂µi
∂β
]−1
·
[
N∑
i=1
∂µ′i
∂β
V −1i (yi −µi)
]
.
Steps 2–7 are iterated until convergence. To illus-
trate step 4, consider compound symmetry, in which
case the correlation is estimated by
α̂=
1
N
N∑
i=1
1
ni(ni − 1)
∑
j 6=k
eijeik.
3.1.2 Weighted generalized estimating equations.
As Liang and Zeger (1986) pointed out, GEE-based
inferences are valid only under MCAR, due to the
fact that they are based on frequentist considera-
tions. An important exception mentioned by these
authors is the situation where the working corre-
lation structure (discussed in the previous section)
happens to be correct, since then the estimates and
model-based standard errors are valid under the
weaker MAR. This is because then the estimating
equations can be interpreted as likelihood equations.
In general, of course, the working correlation struc-
ture will not be correctly specified. The ability to do
so is the core motivation of the method, and there-
fore Robins, Rotnitzky and Zhao (1995) proposed a
class of weighted estimating equations to allow for
MAR, extending GEE.
The idea is to weight each subject’s contribution
in the GEEs by the inverse probability that a subject
drops out at the time he dropped out. This can be
calculated, for example, as
νidi ≡ P [Di = di]
=
di−1∏
k=2
(1−P [Rik = 0|Ri2 = · · ·=Ri,k−1 = 1])
· P [Ridi = 0|Ri2 = · · ·=Ri,di−1 = 1]I{di≤T}.
Recall that we partitioned Yi into the unobserved
components Ymi and the observed components Y
o
i .
Similarly, we can make the exact same partition of
µi into µ
m
i and µ
o
i . In the WGEE approach, which
is proposed to reduce possible bias of βˆ, the score
equations to be solved when taking into account the
correlation structure are
S(β) =
N∑
i=1
1
νidi
∂µi
∂β′
(A
1/2
i CiA
1/2
i )
−1(yi −µi)
=
N∑
i=1
n+1∑
d=2
I(Di = d)
νid
(8)
· ∂µi
∂β′
(d)(A
1/2
i CiA
1/2
i )
−1
· (d)(y(d)−µi(d)) = 0,
where yi(d) and µi(d) are the first d− 1 elements of
yi and µi, respectively. We define ∂µi/∂β
′(d) and
(A
1/2
i CiA
1/2
i )
−1(d) analogously.
It is worthwhile to note that the recently pro-
posed so-called doubly robust method (van der Laan
and Robins, 2003) is more efficient and robust to a
wider class of deviations. However, it is harder to im-
plement than the original proposal. An alternative
mode of analysis, generally overlooked but proposed
by Schafer (2003), consists of multiply imputing the
missing outcomes using a parametric model (e.g., of
a random-effects or conditional type), followed by
conventional GEE and conventional multiple-imputation
inference on the so-completed sets of data.
3.2 Random-Effects Models
Unlike for correlated Gaussian outcomes, the pa-
rameters of the random-effects and population-averaged
models for correlated binary data describe different
types of effects of the covariates on the response
probabilities (Neuhaus, 1992). Therefore, the choice
between population-averaged and random-effects stra-
tegies should heavily depend on the scientific goals.
Population-averaged models evaluate the success
probability as a function of covariates only. With
a subject-specific approach, the response is mod-
eled as a function of covariates and parameters, spe-
cific to the subject. In such models, interpretation of
fixed-effects parameters is conditional on a constant
level of the random-effects parameter. Population-
averaged comparisons, on the other hand, make no
use of within cluster comparisons for cluster vary-
ing covariates and are therefore not useful to assess
within-subject effects (Neuhaus, Kalbfleisch and
Hauck, 1991). While several nonequivalent random-
effects models exist, one of the most popular ones
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is the generalized linear mixed model (Breslow and
Clayton, 1993), implemented in the SAS procedure
NLMIXED. We will focus on this one.
3.2.1 Generalized linear mixed models. A general
formulation of mixed-effects models is as follows. As-
sume that Yi (possibly appropriately transformed)
satisfies
Yi|bi ∼ Fi(θ,bi),(9)
that is, conditional on bi, Yi follows a prespeci-
fied distribution Fi, possibly depending on covari-
ates and parameterized through a vector θ of un-
known parameters common to all subjects. Further-
more bi is a q-dimensional vector of subject-specific
parameters, called random effects, assumed to fol-
low a so-called mixing distribution G which may
depend on a vector ψ of unknown parameters [i.e.,
bi ∼G(ψ)]. The bi reflect the between-unit hetero-
geneity in the population with respect to the dis-
tribution of Yi. In the presence of random effects,
conditional independence is often assumed, under
which the components Yij in Yi are independent,
conditional on bi. The distribution function Fi in
(9) then becomes a product over the ni independent
elements in Yi.
In general, unless a fully Bayesian approach is fol-
lowed, inference is based on the marginal model for
Yi which is obtained by integrating out the random
effects over their distribution G(ψ). Let fi(yi|bi)
and g(bi) denote the density functions that corre-
spond to the distributions Fi and G, respectively.
We have that the marginal density function of Yi
equals
fi(yi) =
∫
fi(yi|bi)g(bi)dbi,(10)
which depends on the unknown parameters θ and ψ.
Assuming independence of the units, estimates of
θ̂ and ψ̂ can be obtained by maximizing the like-
lihood function built from (10), and inferences im-
mediately follow from classical maximum likelihood
theory.
It is important to realize that the random-effects
distribution G is crucial in the calculation of the
marginal model (10). One often assumes G to be of
a specific parametric form, such as a (multivariate)
normal. Depending on Fi and G, the integration in
(10) may or may not be possible analytically. Pro-
posed solutions are based on Taylor series expan-
sions of fi(yi|bi) or on numerical approximations of
the integral, such as (adaptive) Gaussian quadra-
ture.
Note that there is an important difference with
respect to the interpretation of the fixed effects β.
Under the classical linear mixed model (Verbeke and
Molenberghs, 2000), we have that E(Yi) equalsXiβ,
such that the fixed effects have a subject-specific
as well as a population-averaged interpretation. Un-
der nonlinear mixed models, however, this no longer
holds in general. The fixed effects now only reflect
the conditional effect of covariates, and the marginal
effect is no longer easily obtained as E(Yi) is given
by
E(Yi) =
∫
yi
∫
fi(yi|bi)g(bi)dbi dyi.
However, in a biopharmaceutical context, one is of-
ten primarily interested in hypothesis testing and
the random-effects framework can be used to this
effect.
A general formulation of GLMM is as follows.
Conditionally on random effects bi, it assumes that
the elements Yij of Yi are independent, with den-
sity function usually based on a classical exponential
family formulation, that is, with mean E(Yij |bi) =
a′(ηij) = µij(bi) and variance Var(Yij |bi) = φa′′(ηij),
and where, apart from a link function h (e.g., the
logit link for binary data or the Poisson link for
counts), a linear regression model with parameters
β and bi is used for the mean [i.e., h(µi(bi)) =
Xiβ + Zibi]. Note that the linear mixed model is
a special case with identity link function. The ran-
dom effects bi are again assumed to be sampled
from a (multivariate) normal distribution with mean
0 and covariance matrix D. Usually, the canonical
link function is used, that is, h = a′−1, such that
ηi = Xiβ + Zibi. When the link function is cho-
sen to be of the logit form and the random effects
are assumed to be normally distributed, the familiar
logistic-linear GLMM follows.
3.3 Marginal versus Random-Effects Models
It is useful to underscore the difference between
both model families, as well as the nature of this dif-
ference. To see the nature of the difference, consider
a binary outcome variable and assume a random-
intercept logistic model with linear predictor
logit[P (Yij = 1|tij , bi)] = β0 + bi + β1tij , where tij is
the time covariate. The conditional means E(Yij |bi),
as functions of tij , are given by
E(Yij |bi) = exp(β0 + bi + β1tij)
1 + exp(β0 + bi + β1tij)
,(11)
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whereas the marginal average evolution is obtained
by averaging over the random effects,
E(Yij) = E[E(Yij |bi)]
= E
[
exp(β0 + bi + β1tij)
1 + exp(β0 + bi + β1tij)
]
(12)
6= exp(β0 + β1tij)
1 + exp(β0 + β1tij)
.
A graphical representation of both (11) and (12) is
given in Figure 1. This implies that the interpreta-
tion of the parameters in both types of models is
completely different. A schematic display is given in
Figure 2. Depending on the model family (marginal
or random effects), one is led to either marginal or
hierarchical inference. It is important to realize that
in the general case the parameter βM that results
from a marginal model is different from the param-
eter βRE even when the latter is estimated using
marginal inference. Some of the confusion surround-
ing this issue may result from the equality of these
parameters in the very special linear mixed model
case. When a random-effects model is considered,
the marginal mean profile can be derived, but it will
generally not produce a simple parametric form. In
Figure 2 this is indicated by putting the correspond-
ing parameter within quotes.
As an important example, consider our GLMM
with logit link function, where the only random ef-
fects are intercepts bi. It can then be shown that the
marginal mean µi = E(Yij) satisfies h(µi) ≈XiβM
with
βRE
βM
=
√
c2σ2 +1> 1,(13)
in which c equals 16
√
3/15pi. Hence, although the
parameters βRE in the generalized linear mixed model
have no marginal interpretation, they do show a
strong relationship to their marginal counterparts.
Note that, as a consequence of this relationship,
larger covariate effects are obtained under the random-
effects model in comparison to the marginal model.
4. ANALYSIS OF FIRST CASE STUDY
Let us now analyze the motivating clinical trial.
Therapies are recorded as A1 for primary dose of ex-
perimental drug, while B refers to nonexperimental
drug and C refers to placebo. The primary contrast
is between A1 and C. Emphasis is on the difference
between arms at the end of the study. A graphical
representation of the dropout, per study and per
arm, is given in Figure 3.
The primary null hypothesis (zero difference be-
tween the treatments and placebo in terms of pro-
portion of the HAMD17 total score above the level
of 7) will be tested using both marginal models (GEE
and WGEE) and random-effects models (GLMM).
According to the study protocol, the models will
include the fixed categorical effects of treatment,
visit and treatment-by-visit interaction, as well as
the continuous, fixed covariates of baseline score and
baseline score-by-visit interaction. A random inter-
cept will be included when considering the random-
effects models. Analyses will be implemented using
the SAS procedures GENMOD and NLMIXED.
Missing data will be handled in three different
ways: (1) imputation using LOCF, (2) deletion of
incomplete profiles, leading to a CC, and (3) ana-
lyzing the data as they are, consistent with ignor-
ability (for GLMM and WGEE). A fully longitudi-
nal approach (View 1) is considered in Section 4.1.
Section 4.2 compares the results of the marginal
and random-effects models. Section 4.3 focuses on
Views 2 (treatment effect at last planned occasion)
and 3 (last measurement obtained).
4.1 View 1: Longitudinal Analysis
4.1.1 Marginal models. First, let us consider the
GEE approach. Within the SAS procedure GEN-
MOD, the exchangeable working correlation matrix
is used.
An inspection of parameter estimates and stan-
dard errors (not shown) reveals that the interaction
between treatment and time is nonsignificant. The
same holds in the analyses that will be done subse-
quently. At first sight, this suggests model simplifi-
cation. However, there are a few reasons to prefer
a different route. First, as stated before, a longitu-
dinal model used in a regulatory, controlled envi-
ronment is ideally sufficiently generally specified to
avoid driving conclusions through models that are
too simple. Sticking to a single, prespecified model
also avoids dangers associated with model selection
(e.g., inflated type I errors) recently reported in the
literature (Hjort and Claeskens, 2003). Second, a
general model allows for, as a by-product, assess-
ment of treatment effect at the last planned occa-
sion. Third, one can still assess the important null
hypothesis of (1) no average treatment effect and
(2) no treatment effect at any of the measurement
occasions. These tests have been conducted and are
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Fig. 1. Graphical representation of a random-intercept logistic curve across a range of levels of the random intercept, together
with the corresponding marginal curve.
reported in Table 2; for (1), also the estimated av-
erage treatment effect is reported.
In many cases, the empirically corrected standard
errors are larger than the model-based ones. This is
because model-based standard errors are the ones
that would be obtained if the estimating equations
were true likelihood equations, that is, when the
working correlation structure is correct. In such cases
likelihood inference enjoys optimality. However, since
the working correlation structure is allowed to be
misspecified, model-based standard errors will be bi-
Fig. 2. Representation of model families and corresponding inference. A superscript M stands for marginal; RE denotes
random effects. A parameter within quotes indicates that marginal functions but no direct marginal parameters are obtained.
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ased and it is advisable to base conclusions on em-
pirically corrected standard errors.
Turning to WGEE, the method is applied to per-
form an analysis that is correct under MAR, not
only under MCAR as in ordinary GEE. This proce-
dure is a bit more involved in terms of fitting the
model to the data. We will outline the main steps.
The SAS code is available from the authors upon
request.
To compute the necessary weights, we first fit the
dropout model using logistic regression. The out-
come drop is binary and indicates whether or not
dropout occurs at a given time. The response value
at the previous occasion (prevhamd) and treatment
are included as covariates. Next, the predicted prob-
abilities of dropout are translated into weights, de-
fined at the individual measurement level. Let us de-
scribe the procedure to construct the inverse weights.
At the first occasion define wi1 = 1. At other than
Fig. 3. Evolution of dropout per study and per treatment arm. Treatment arms A1 and C, being the ones of primary interest,
are shown by the solid and dashed lines, respectively.
Table 2
Depression trial, View 1: GEE, WGEE and GLMM. Tests for (1) the joint null hypothesis of no treatment effect at none
of the time points and (2) the hypothesis of no average treatment effect
Joint effects Mean effects
A1 B A1 & B1 A1 B A1 & B1
(8 d.f.) (8 d.f.) (16 d.f.) (1 d.f.) (1 d.f.) (2 d.f.)
Analysis p p p p (est., s.e.) p (est., s.e.) p
CC (GEE) 0.4278 0.9859 0.8444 0.5259 (−2.66; 4.19) 0.9165 (0.47; 4.50) 0.5845
LOCF (GEE) 0.7008 0.9956 0.9768 0.7713 (−1.15; 3.96) 0.9070 (0.49; 4.19) 0.8605
MAR (GEE) 0.6465 0.9931 0.9413 0.6015 (−1.92; 3.67) 0.8671 (0.65; 3.89) 0.6804
MAR (WGEE) 0.1690 0.7601 0.5372 0.5477 (2.61; 4.34) 0.3883 (3.97; 4.60) 0.7224
CC (GLMM) 0.7572 0.9743 0.7233 0.4954 (−0.40; 0.59) 0.2671 (0.64; 0.57) 0.0440
LOCF (GLMM) 0.7363 0.9953 0.9763 0.1571 (−0.66; 0.47) 0.4555 (−0.34; 0.45) 0.3611
MAR (GLMM) 0.7476 0.9738 0.7152 0.4495 (−0.41; 0.55) 0.2844 (0.58; 0.54) 0.0375
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the last occasion, the quantity of interest equals the
cumulative weight over the previous occasions, mul-
tiplied by (1− the predicted probability of dropout).
At the last occasion within a sequence where dropout
occurs, it is multiplied by the predicted probability
of dropout. At the end of the process this quan-
tity is inverted to yield the actual weight. After
these preparations we merely need to include the
weights by means of the scwgt statement within the
GENMOD procedure. Together with the use of the
repeated statement, WGEE follows. Also here we
use the exchangeable working correlation matrix.
Let us now turn to the results. The marginal mod-
els reveal nonsignificant treatment effects in all cases,
for either the composite hypothesis of no treatment
effects or the hypotheses of no average effects. This
holds for both arms separately, as well as for the
two arms jointly. Corresponding to the 1-degree-of-
freedom (d.f.) tests, parameter estimates and stan-
dard errors can be estimated as well. For concise-
ness, only empirically corrected standard errors are
shown. A strong difference is observed between the
WGEE and other cases. Since this is the only one
valid under MAR, it is clear that there are dangers
associated with methods that are too simple. Fur-
thermore, some of the CC p-values are smaller than
their MAR and LOCF counterparts.
4.1.2 Random-effect models. To fit generalized lin-
ear mixed models, we use the SAS procedure
NLMIXED, which allows fitting a wide class of lin-
ear, generalized linear and nonlinear mixed models.
It relies on numerical integration. Not only are dif-
ferent integral approximations available, the princi-
pal ones being (adaptive) Gaussian quadrature, it
also includes a number of optimization algorithms.
The difference between nonadaptive and adaptive
Gaussian quadrature is that for the first procedure
the quadrature points are centered at zero for each
of the random effects and the current random-effects
covariance matrix is used as the scale matrix, while
for the latter the quadrature points will be appropri-
ately centered and scaled, such that more quadra-
ture points lie in the region of interest (Molenberghs
and Verbeke, 2005). We will use both adaptive and
nonadaptive quadrature, with several choices for the
number of quadrature points, to check the stability
of the results over a variety of choices for these nu-
merical choices.
Precisely, we initiate the model fitting using non-
adaptive Gaussian quadrature, together with the
quasi-Newton optimization algorithm. The number
of quadrature points is left to be determined by
the procedure, and all starting values are set equal
Fig. 4. The effect of adaptive versus nonadaptive quadrature, quasi-Newton versus Newton–Raphson and the number of
quadrature points on the treatment effect parameter for arm A1.
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to 0.5. Using the resulting parameter estimates, we
keep these choices but hold the number of quadra-
ture points fixed (2, 3, 5, 10, 20 and 50). Subse-
quently, we switch to adaptive Gaussian quadra-
ture (step 2). Finally, the quasi-Newton optimiza-
tion is replaced by the Newton–Raphson optimiza-
tion (step 3). The effect of the method and the
number of quadrature points is graphically repre-
sented in Figure 4 for a selected parameter (treat-
ment effect of A1). While the differences between
these choices are purely numerical, we do notice dif-
ferences between the results, illustrating that a nu-
merical sensitivity analysis matters. The parameter
estimates tend to stabilize with increasing number of
quadrature points. However, nonadaptive Gaussian
quadrature needs obviously more quadrature points
than adaptive Gaussian quadrature.
Focusing on the results for 50 quadrature points,
we observe that the parameter estimates for steps
1 and 2 are the same. On the other hand, parame-
ter estimates for step 3 are different (order of 10−3,
visible in p-values). In spite of the differences in pa-
rameter estimates, it is noteworthy that the likeli-
hood is the same in all steps, due to a flat likelihood.
This was confirmed by running all steps again using
the parameter estimates of step 3 as starting values,
at which point the parameter estimates all coincide.
Thus, it may happen that the optimization routine
has only seemingly converged.
Exactly as in the marginal model case, we assessed
average treatment effect as well as treatment effect
at any of the times. The results are reported in Ta-
ble 2 as well. The parameter p-values are more var-
ied across methods than in the marginal model case.
The most striking feature is that there is evidence
for a treatment effect in the two groups together,
under MAR, and also with CC. Note that the cor-
responding 1-degree-of-freedom tests do not show
significance. In the LOCF case some p-values are
smaller, while others are larger. This contradicts a
common belief that LOCF is conservative. Molen-
berghs et al. (2004) have shown that both conserva-
tive and liberal behavior is possible.
4.2 Marginal versus Random-Effects Models
In all cases, the variability of the random effect
(standard deviation parameter σ) is highly signif-
icant. This implies that the GEE parameters and
the random-effects parameters cannot be compared
directly. If the conversion factor (13) is computed,
then one roughly finds a factor of about 2.5. We
note that this factor is not reproduced when the two
sets of estimates (estimates not shown) are directly
compared. This is due to the fact that (13) oper-
ates at the true population parameter level, while
we only have parameter estimates at our disposal.
Since many of the estimates are only marginally or
not significant, it is not unexpected, therefore, to ob-
serve deviations from this relationship, even though
the general tendency is preserved in most cases.
4.3 Views 2 and 3: Single Time Point Analysis
When emphasis is on the last measurement oc-
casion, LOCF and CC are straightforward to use.
When the last observed measurement is of interest
(a different scientific question), the analysis is not
different from the one obtained under LOCF, but,
of course, in this case CC is not an option.
Since the outcome is a dichotomous response, the
data can be summarized in a 2× k table, where k
represents the number of treatments. The analysis
essentially consists of comparing the proportions of
success or failure in all groups. For this purpose,
both Pearson’s chi-squared test (Agresti, 1990) and
Fisher’s exact test (Freeman and Halton, 1951) will
be used. Nevertheless, it is still possible to obtain in-
ferences from a full longitudinal model in this con-
text. We add these for the sake of reference, but
it should be understood that the analysis using a
simple model for the last time point only is more
in line with practice. When an ignorable analysis
is considered, one has to explicitly consider all in-
complete profiles in order to correctly incorporate
all information available. Thus, one has to consider
a longitudinal model.
Placebo C is considered as the reference treat-
ment. Let αi be the effect of treatment arm i at the
last measurement occasion, where i = A1, B or C.
We wish to test whether, at the last measurement
occasion, all treatment effects are equal. This trans-
lates into αA1 = αB = αC or, equivalently, into αA1−
αC = αB − αC = 0. Such contrasts can be obtained
very easily using the SAS procedure NLMIXED. Ta-
ble 3 shows a summary of the results in terms of
p-values.
The GLMMs lead to a small difference between
CC and MAR: both are borderline. On the other
hand, the GLMM for LOCF leads to a nonsignif-
icant result. An endpoint analysis (i.e., using the
last available measurement) shows the same result
for LOCF (nonsignificant), whereas the result for
CC becomes significant. An endpoint analysis leads
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Table 4
Age related macular degeneration trial. Parameter estimates (model-based standard errors; empirically
corrected standard errors) for the marginal models: GEE on the CC and LOCF population, and on the
observed data;
in the latter case WGEE is also used
Observed data
Effect Parameter CC LOCF Unweighted WGEE
Int. 4 β11 −1.01 (0.24; 0.24) −0.87 (0.20; 0.21) −0.87 (0.21; 0.21) −0.98 (0.10; 0.44)
Int. 12 β21 −0.89 (0.24; 0.24) −0.97 (0.21; 0.21) −1.01 (0.21; 0.21) −1.78 (0.15; 0.38)
Int. 24 β31 −1.13 (0.25; 0.25) −1.05 (0.21; 0.21) −1.07 (0.22; 0.22) −1.11 (0.15; 0.33)
Int. 52 β41 −1.64 (0.29; 0.29) −1.51 (0.24; 0.24) −1.71 (0.29; 0.29) −1.72 (0.25; 0.39)
Trt. 4 β12 0.40 (0.32; 0.32) 0.22 (0.28; 0.28) 0.22 (0.28; 0.28) 0.80 (0.15; 0.67)
Trt. 12 β22 0.49 (0.31; 0.31) 0.55 (0.28; 0.28) 0.61 (0.29; 0.29) 1.87 (0.19; 0.61)
Trt. 24 β32 0.48 (0.33; 0.33) 0.42 (0.29; 0.29) 0.44 (0.30; 0.30) 0.73 (0.20; 0.52)
Trt. 52 β42 0.40 (0.38; 0.38) 0.34 (0.32; 0.32) 0.44 (0.37; 0.37) 0.74 (0.31; 0.52)
Corr. ρ 0.39 0.44 0.39 0.33
Table 3
Depression trial, Views 2 and 3: p-values are reported
(mixed refers to the assessment of treatment at the last visit
based on a generalized linear mixed model)
Method Model p-Value
CC Mixed 0.0463
Pearson’s chi-squared test 0.0357
Fisher’s exact test 0.0336
LOCF Mixed 0.1393
Pearson’s chi-squared test 0.1553
Fisher’s exact test 0.1553
MAR Mixed 0.0500
to a completely different picture, with results that
are strongly different (significant) from the GLMM
model. This illustrates that the choice between mod-
eling techniques is far from an academic question,
but can have profound impact on the study conclu-
sions, ranging from highly significant over borderline
(non)significant to highly nonsignificant.
5. ANALYSIS OF THE SECOND CASE STUDY
We compare analyses performed on the completers
only (CC), on the LOCF imputed data and on the
observed data. For the observed, partially incom-
plete data, GEE is supplemented with WGEE. Fur-
thermore, a random-intercepts GLMM is considered,
based on numerical integration. The GEE analyses
are reported in Table 4 and the random-effects mod-
els in Table 5. For GEE, a working exchangeable
correlation matrix is considered. The model has four
intercepts and four treatment effects. To be precise,
the marginal regression model takes the form
logit[P (Yij = 1|Ti)] = βj1 + βj2Ti,
where j = 1, . . . ,4 refers to measurement occasion,
Ti is the treatment assignment for subject i= 1, . . . ,240
and Yij is the indicator for whether or not three lines
of vision have been lost for subject i at time j. The
advantage of having separate treatment effects at
each time is that particular attention can be given to
the treatment effect assessment at the last planned
measurement occasion (i.e., after one year). From
Table 4 it is clear that the model-based and em-
pirically corrected standard errors agree extremely
well. This is due to the unstructured nature of the
Table 5
Age related macular degeneration trial. Parameter estimates
(standard errors) for the random-intercept models:
Numerical-integration-based fits (adaptive Gaussian
quadrature) on the CC and LOCF population,
and on the observed data (direct-likelihood)
Direct
Effect Parameter CC LOCF likelihood
Int. 4 β11 −1.73 (0.42) −1.63 (0.39) −1.50 (0.36)
Int. 12 β21 −1.53 (0.41) −1.80 (0.39) −1.73 (0.37)
Int. 24 β31 −1.93 (0.43) −1.96 (0.40) −1.83 (0.39)
Int. 52 β41 −2.74 (0.48) −2.76 (0.44) −2.85 (0.47)
Trt. 4 β12 0.64 (0.54) 0.38 (0.52) 0.34 (0.48)
Trt. 12 β22 0.81 (0.53) 0.98 (0.52) 1.00 (0.49)
Trt. 24 β32 0.77 (0.55) 0.74 (0.52) 0.69 (0.50)
Trt. 52 β42 0.60 (0.59) 0.57 (0.56) 0.64 (0.58)
R.I. s.d. τ 2.19 (0.27) 2.47 (0.27) 2.20 (0.25)
R.I. var. τ 2 4.80 (1.17) 6.08 (1.32) 4.83 (1.11)
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full time by treatment mean structure. However, we
do observe differences in the WGEE analyses. Not
only are the parameter estimates mildly different be-
tween the two GEE versions, but there is a dramatic
difference between the model-based and empirically
corrected standard errors. Nevertheless, the two sets
of empirically corrected standard errors agree very
closely, which is reassuring.
When comparing parameter estimates across CC,
LOCF and observed data analyses, it is clear that
LOCF has the effect of artificially increasing the cor-
relation between measurements. The effect is mild in
this case. The parameter estimates of the observed-
data GEE are close to the LOCF results for earlier
time points and close to CC for later time points.
This is to be expected, because at the start of the
study the LOCF and observed populations are vir-
tually the same, with the same holding between CC
and observed populations near the end of the study.
Note also that the treatment effect under LOCF, es-
pecially at 12 weeks and after 1 year, is biased down-
ward in comparison to the GEE analyses. To prop-
erly use the information in the missingness process,
WGEE can be used. To this end, a logistic regression
for dropout, given covariates and previous outcomes,
needs to be fitted. Parameter estimates and stan-
dard errors are given in Table 6. Intermittent miss-
ingness will be ignored. Covariates of importance are
treatment assignment, the level of lesions at baseline
(a four-point categorical variable, for which three
dummies are needed) and time at which dropout oc-
curs. For the latter covariates, there are three levels,
since dropout can occur at times 2, 3 or 4. Hence,
two dummy variables are included. Finally, the pre-
vious outcome does not have a significant impact,
but will be kept in the model nevertheless. In spite
of there being no strong evidence for MAR, the re-
sults between GEE and WGEE differ quite a bit. It
is noteworthy that at 12 weeks, a treatment effect
is observed with WGEE that goes unnoticed with
the other marginal analyses. This finding is mildly
confirmed by the random-intercept model when the
data as observed are used.
The results for the random-effects models are given
in Table 5. We observe the usual relationship be-
tween the marginal parameters of Table 4 and their
random-effects counterparts. Note also that the
random-intercepts variance is largest under LOCF,
underscoring again that this method artificially in-
creases the association between measurements on
the same subject. In this case, unlike for the marginal
Table 6
Age related macular degeneration trial.
Parameter estimates (standard errors) for a
logistic regression model to describe dropout
Effect Parameter Estimate (s.e.)
Intercept ψ0 0.14 (0.49)
Previous outcome ψ1 0.04 (0.38)
Treatment ψ2 −0.86 (0.37)
Lesion level 1 ψ31 −1.85 (0.49)
Lesion level 2 ψ32 −1.91 (0.52)
Lesion level 3 ψ33 −2.80 (0.72)
Time 2 ψ41 −1.75 (0.49)
Time 3 ψ42 −1.38 (0.44)
models, LOCF and in fact also CC slightly to consid-
erably overestimate the treatment effect at certain
times, in particular at 4 and 24 weeks.
6. DISCUSSION
In this paper we have indicated that a variety of
approaches is possible when analyzing incomplete
longitudinal data from clinical trials. First, unlike in
the continuous case where the linear mixed model
is the main mode of analysis, one has the choice
between a marginal model (generalized estimating
equations, GEE) and a random-effects approach (gen-
eralized linear mixed models, GLMM). While these
may provide similar results in terms of hypothesis
testing, things are different when the models are
used for estimation purposes, because the param-
eters have quite different meanings. Both GEE and
GLMM can be used when data are incomplete. For
GLMM this holds under the fairly general assump-
tion of an MARmechanism, while for GEE the stronger
MCAR is required. However, GEE can be extended
to weighted GEE, making it also valid under MAR.
Current statistical computing power has brought both
GLMM and WGEE within reach, and we have im-
plemented such analyses in the real-life setting of
clinical trials on depression and on macular degener-
ation. This underscores that simple but potentially
highly restrictive modes of analyses, such as CC or
LOCF, should no longer be seen as the preferred
mode of analysis. This message is in line with the
one reached for continuous outcomes (Molenberghs
et al., 2004).
While in the studies considered here there are
no extreme differences between the various analy-
ses conducted, some differences are noticeable, es-
pecially in the second case study (Molenberghs et
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al., 2004). So, generally, caution should be used and
it is best to move away from the overly simple meth-
ods.
Note that such a full longitudinal approach un-
der MAR is also very sensible, even when one is
interested in an effect at one particular scheduled
measurement occasion, say, the treatment effect at
the last scheduled visit. Indeed, an ignorable anal-
ysis takes all information into account, not only from
complete observations, but also from incomplete ones,
through the conditional expectation of the missing
measurements given the observed ones. Thus, when
combined with an analysis where the treatment al-
location is used “as randomized” rather than “as
treated,” such an approach is fully compatible with
the intention-to-treat principle.
When there is residual doubt about the plausibil-
ity of MAR, one can conduct a sensitivity analysis.
Many proposals have been made, but this remains
an active area of research. Obviously, a number of
MNARmodels can be fitted, provided one is prepared
to approach formal aspects of model comparison
with due caution. Such analyses can be complemented
with appropriate (global and/or local) influence anal-
yses. Some sensitivity analyses frameworks have been
provided by Rotnitzky, Robins and Scharfstein (1998),
Forster and Smith (1998), Raab and Donnelly (1999),
Kenward, Goetghebeur and Molenberghs (2001),
van Steen, Molenberghs, Verbeke and Thijs (2003)
and Jansen et al. (2003).
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